Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиSeres Therapeutics Мультипликаторы 2011-2024 | MCRB
Мультипликаторы по годам Seres Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.2 | -2.3 | -11.2 | -17.0 | -2.7 | -2.5 | -4.7 | -4.1 | -11.6 | - | - | - | - |
P/S |
1.1 | 79.8 | 5.1 | 45.7 | 5.5 | 8.8 | 13.1 | 17.2 | - | - | - | - | - |
EPS |
-0.9 | -2.3 | -0.7 | -1.1 | -1.2 | -2.4 | -2.2 | -2.3 | -2.3 | -2.7 | -1.1 | - | - |
EV (Enterprise Value) |
412 млн | 743 млн | 769 млн | 1.57 млрд | 305 млн | 332 млн | 514 млн | 460 млн | 571 млн | 29.9 млн | 11.6 млн | - | - |
EBITDA per Share |
-0.79 | -2.22 | -0.64 | -1.02 | -1.11 | -2.27 | -2.08 | -2.22 | -2.3 | - | - | - | - |
EV/EBITDA |
-13.3 | -23.2 | -2.4 | -1.8 | -4.6 | -3.6 | -10.3 | - | - | - | - | ||
PEG |
-0.07 | -0.07 | 0.6 | 1.42 | -0.05 | 0.25 | -1.21 | -3.18 | 0.05 | - | - | - | - |
P/B |
-3.1 | 52.7 | 5.6 | 8.7 | -3.9 | -5.2 | 6.9 | 2.8 | 3.1 | - | - | - | - |
P/CF |
-1.2 | -2.5 | 109.7 | -16.2 | -2.4 | -3.9 | -5.3 | 16.7 | -14.0 | - | - | - | - |
ROE % |
253.53 | -2319.92 | -49.87 | -51.00 | 145.43 | 205.94 | -147.25 | -69.05 | -26.67 | - | - | - | - |
ROA % |
-31.71 | -71.72 | -18.48 | -25.99 | -53.06 | -82.13 | -47.16 | -33.59 | -25.26 | - | - | - | - |
ROCE % |
240.73 | -2285.91 | -49.04 | -50.43 | -81.42 | -127.86 | -57.88 | -38.33 | -26.63 | - | - | - | - |
Current Ratio |
0.9 | 1.0 | 1.6 | 2.0 | 2.2 | 2.2 | 4.9 | 6.5 | 19.0 | - | - | - | - |
DSO |
- | - | - | 9.8 | 18.9 | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | 9.8 | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | 9.8 | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Seres Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | 0.36 | -0.57 | - | -0.49 | -0.7 | -0.61 | - | 0.74 | -0.53 | -0.39 | - | -0.36 | -0.28 | -0.28 | -0.27 | -0.23 | -0.24 | -0.59 | -0.52 | -0.54 | -0.68 | -0.69 | -0.72 | -0.17 | -0.69 | -0.63 | -0.63 | -0.46 | -0.7 | -0.5 | -0.5 | -0.38 | -1.45 | -1.15 | -1.24 | -0.68 | -0.45 | -0.29 | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.36 | 0.4 | -0.55 | - | -0.47 | -0.67 | -0.59 | - | 0.76 | -0.51 | -0.37 | - | -0.34 | -0.26 | -0.25 | -0.27 | -0.22 | -0.2 | -0.55 | -0.53 | -0.5 | -0.64 | -0.65 | -0.73 | -0.13 | -0.66 | -0.6 | -0.64 | -0.44 | -0.69 | -0.5 | -0.51 | -0.37 | -1.41 | -0.93 | -1.05 | -0.52 | -0.38 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
582.19 | 176.97 | -309.63 | -439.47 | -400.65 | -273.06 | -40.13 | -33.68 | -51.01 | -107.15 | -71.19 | -40.56 | -1.70 | 49.58 | 83.70 | 145.43 | 150.88 | 162.61 | 198.18 | 205.94 | 113.93 | 56.82 | -47.17 | -147.25 | -118.61 | -121.27 | -96.16 | -69.05 | -59.55 | -52.58 | -37.65 | -26.67 | 13.51 | 36.20 | 52.33 | 56.21 | 25.59 | 10.02 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-47.14 | -53.37 | -82.52 | -54.64 | -37.43 | 16.73 | -1.20 | -12.31 | -21.14 | -47.18 | -35.30 | -20.67 | -34.85 | -38.41 | -40.49 | -53.06 | -56.56 | -62.39 | -77.33 | -82.13 | -79.74 | -65.18 | -56.89 | -47.16 | -41.15 | -44.35 | -39.80 | -33.59 | -33.37 | -33.26 | -28.81 | -25.26 | -23.18 | -19.98 | -16.47 | -12.80 | -5.83 | -2.28 | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
592.47 | 191.50 | -302.13 | -430.96 | -392.03 | -265.65 | -38.65 | -33.29 | -50.46 | -106.55 | -70.67 | -40.19 | -0.47 | 52.25 | 86.66 | 148.74 | 154.13 | 164.80 | 200.71 | 208.73 | 114.57 | 56.29 | -49.09 | -150.57 | -120.89 | -123.23 | -97.63 | -70.00 | -60.26 | -52.96 | -37.75 | -26.71 | 9.92 | 30.40 | 46.21 | 50.19 | 23.19 | 9.80 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.0 | 1.1 | 0.8 | 1.0 | 1.3 | - | 1.3 | 1.6 | 1.8 | 1.6 | 1.9 | 2.0 | 2.0 | 2.0 | 2.0 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 1.5 | 1.5 | 1.5 | 1.5 | 1.9 | 1.9 | 1.9 | 1.9 | 18.9 | 18.9 | 18.9 | 18.9 | 14.7 | 14.7 | 14.7 | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | 0.9 | 33.4 | 95.7 | - | 604.5 | 141.7 | 62.2 | - | 23.2 | 13.0 | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | 0.9 | 33.4 | 95.7 | - | 604.5 | 141.7 | 62.2 | - | 23.2 | 13.0 | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | 0.9 | 33.4 | 95.7 | - | 604.5 | 141.7 | 62.2 | - | 23.2 | 13.0 | 11.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD